Israeli biotech Compugen announced that the protein CGEN-15022, discovered by the company, has the potential for treating liver, colorectal, lung and ovarian cancers through monoclonal antibody (mAb) therapy.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000760767&fid=1725
A protein to treat multiple cancers
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.